Weight loss is not a safe, effective, or permanent method of health promotion, and pharmacotherapeutical approaches pose specific risks to adolescents.
AMA J Ethics. 2023; 25(7):E478-495. doi:
10.1001/amajethics.2023.478.
Before the late 20th century, overweight and obesity were not considered population-wide health risks, but the advent of weight loss drugs in the 1990s accelerated hypermedicalization via BMI use.
AMA J Ethics. 2023; 25(7):E550-558. doi:
10.1001/amajethics.2023.550.
Underlying ideological foundations of stigma and equipment inadequacy include thin-centrism and inadequate representation of fat people in health care organizational leadership.
AMA J Ethics. 2023; 25(7):E528-534. doi:
10.1001/amajethics.2023.528.
Size-based health and beauty ideals emanated from eugenic pseudoscientific postulates, and BMI continues to advance white supremacist embodiment norms.
AMA J Ethics. 2023; 25(7):E535-539. doi:
10.1001/amajethics.2023.535.
Diagnostic utility of weight and body mass index is widely overestimated, and their use as health and wellness measures can be sources of iatrogenic harm.
AMA J Ethics. 2023; 25(7):E540-544. doi:
10.1001/amajethics.2023.540.
While useful in analyzing population trends in relative body weight, BMI possesses multiple shortcomings when used as an individualized health screening tool.
AMA J Ethics. 2023; 25(7):E545-549. doi:
10.1001/amajethics.2023.545.
Dr Anne Graff LaDisa joins Ethics Talk to discuss her article, coauthored with Drs Erica Chou, Amy Zelenski, and Sara Lauck: “How to Use Improv to Help Interprofessional Students Respond to Status and Hierarchy in Clinical Practice.”